Website for ASAAP Malaria Project

ASAAP Malaria is a 4-year clinical trial research to evaluate the efficacy, safety, tolerability and pharmacokinetics of a new antimalarial combination drug, with particular focus on its successful application in one of the largest and most vulnerable demographics of Africa – i.e. children 0-5 years old.

As part of its plans to make findings from the trial visible and accessible to a wide range of stakeholders as well as to networks of individuals and institutions, ASAAP contracted LugiWeb to build a website dedicated to the trial and to antimalarial therapy. The website was to provide, not only updates on the progress of the trial and related activities and events, but also information on research (past and on-going) on antimalarial therapy, including findings from the trial.